These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1971278)

  • 1. Determination of remoxipride in plasma and urine by reversed-phase column liquid chromatography.
    Nilsson LB
    J Chromatogr; 1990 Mar; 526(1):139-50. PubMed ID: 1971278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High sensitivity determination of the remoxipride hydroquinone metabolite NCQ-344 in plasma by coupled column reversed-phase liquid chromatography and electrochemical detection.
    Nilsson LB
    Biomed Chromatogr; 1998; 12(2):65-8. PubMed ID: 9568272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-line low-level radiometric detection of [14C]remoxipride in liquid chromatographic effluents. Application to urine samples.
    Veltkamp AC; Das HA; Frei RW; Brinkman UA
    J Chromatogr; 1987 Jan; 384():357-69. PubMed ID: 2880858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic determination of nemonapride and desmethylnemonapride in human plasma using an electrochemical detection.
    Nagasaki T; Ohkubo T; Sugawar K; Yasui N; Ohtani K; Kaneko S
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):293-8. PubMed ID: 9766869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of remoxipride in human plasma and urine by reversed-phase ion-pair high-performance liquid chromatography.
    Chiou RH; Lo MW
    J Chromatogr; 1992 Oct; 581(2):300-5. PubMed ID: 1452624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of risperidone in plasma by high-performance liquid chromatography with electrochemical detection: application to therapeutic drug monitoring in schizophrenic patients.
    Aravagiri M; Marder SR; Van Putten T; Midha KK
    J Pharm Sci; 1993 May; 82(5):447-9. PubMed ID: 7689651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validated high-performance liquid chromatographic assay for the determination of promazine in human plasma. Application to pharmacokinetic studies.
    Larsimont V; Meins J; Fieger-Büschges H; Blume H
    J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):222-6. PubMed ID: 9869384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective determination of R-(+)- and S-(-)-remoxipride, a dopamine D2-receptor antagonist, in human plasma by chiral high-performance liquid chromatography.
    DePuy ME; Demetriades JL; Musson DG; Rogers JD
    J Chromatogr B Biomed Sci Appl; 1997 Oct; 700(1-2):165-73. PubMed ID: 9390726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized method for the determination of itopride in human plasma by high-performance liquid chromatography with fluorimetric detection.
    Ptácek P; Klíma J; Macek J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Mar; 877(8-9):842-6. PubMed ID: 19246254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of a potential anxiolytic drug (CGS 20625) in human plasma by high-performance liquid chromatography.
    Brunner LA; Luders RC
    J Chromatogr; 1991 Aug; 568(2):487-93. PubMed ID: 1686029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An early phase II clinical trial of remoxipride in schizophrenia with measurement of plasma neuroleptic activity.
    Chouinard G; Turnier L
    Psychopharmacol Bull; 1986; 22(1):267-71. PubMed ID: 2873615
    [No Abstract]   [Full Text] [Related]  

  • 12. Simplified ultraviolet liquid chromatographic method for determination of sertindole, dehydrosertindole and norsertindole, in human plasma.
    Canal-Raffin M; Déridet E; Titier K; Frakra E; Molimard M; Moore N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(1):61-7. PubMed ID: 15607708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic determination of the X-ray imaging contrast agent, iofratol, in plasma and urine.
    Arbughi T; Bertani F; Celeste R; Grotti A; Tirone P
    J Chromatogr B Biomed Sci Appl; 1997 Nov; 701(1):103-13. PubMed ID: 9389344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated determination of clozapine and major metabolites in serum and urine.
    Weigmann H; Bierbrauer J; Härtter S; Hiemke C
    Ther Drug Monit; 1997 Aug; 19(4):480-8. PubMed ID: 9263393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remoxipride: pharmacokinetics and effect on plasma prolactin.
    Movin-Osswald G; Hammarlund-Udenaes M
    Br J Clin Pharmacol; 1991 Sep; 32(3):355-60. PubMed ID: 1685665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatographic studies on the aqueous solution conformation of substituted benzamides related to remoxipride.
    Clark CR; Smith FT; Clark MR; Garcia-Roura LE
    J Chromatogr Sci; 1990 Mar; 28(3):93-6. PubMed ID: 1980276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of urinary pH on the plasma and urinary kinetics of remoxipride in man.
    Widerlöv E; Termander B; Nilsson MI
    Eur J Clin Pharmacol; 1989; 37(4):359-63. PubMed ID: 2574673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of clozapine and its N-desmethyl metabolite by high-performance liquid chromatography with ultraviolet detection.
    Llerena A; Berecz R; Norberto MJ; de la Rubia A
    J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):349-54. PubMed ID: 11393724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of remoxipride in plasma and cerebrospinal fluid in sheep.
    Main DC; Waterman AE; Kilpatrick IC
    J Vet Pharmacol Ther; 1996 Oct; 19(5):402-4. PubMed ID: 8905576
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug interaction studies with remoxipride.
    Yisak W; von Bahr C; Farde L; Grind M; Mattila M; Ogenstad S
    Acta Psychiatr Scand Suppl; 1990; 358():58-62. PubMed ID: 1978492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.